Industry

Europe’s largest cancer research meeting, the ESMO Virtual Congress, recently took place on Sept. 19-21. With the event behind us, STAT’s Adam Feuerstein will moderate a panel with some top cancer experts to review the significant data presented at ESMO, discuss what to expect for the rest of the year…

Thomas George, MD, Associate Professor of Medicine, Department of Medicine, Hematology/Oncology RAS is a common mutation in malignancies yet historically is difficult to inhibit. AMG 510 is a new KRASG12C inhibitor with activity in non‒small cell…